And since this global killer shows no signs of stopping any time soon, it’s important to take realistic, natural steps to avoid cancer. I’m not saying to avoid getting conventional medical treatments in all cancer cases; but I am saying that if you’ve been diagnosed with cancer, that you absolutely need to add these powerful steps to your treatment regimen.

The following steps will help you to avoid cancer, and they can potentially help to slow, or even reverse the aging process, increase energy levels and help your body to ward off a whole host of health problems.

In the words of the director of the Foundation Executive Director Sales, the results of tests on animals have been “spectacular.” 80% of vaccinated mice were cured, while in 100% of diseased mice that were not vaccinated melanoma caught.

The results of this new development in medicine have been published in The Journal of Immunology.

A team of researchers from the University of Michigan has created the nanotechnology equivalent of a Trojan Horse to carry a powerful chemotherapy in tumor cells, thereby increasing the drug’s ability to kill cancer cells and reducing side effects toxic.

According to a press release released yesterday by the University, previous studies in cell cultures show that the use of nanoparticles to transport anti-cancer treatments directly to the target, ie, tumor cells may increase the therapeutic response. Now scientists at Michigan have shown that this treatment based on nanotechnology, is effective in living animals.

According to the study director, Professor James Baker, “This is the first study that has shown how a drug transported by a nanoparticle can leave the bloodstream to reach cancer cells and have a biological impact on the animal’s tumor. “

Baker stresses the optimism of his team before this achievement because in his opinion shows that nanotechnology can markedly improve current cancer therapies. “Send treatments directly to cancer cells reduces the amount reaching normal cells, increases the impact of anti-cancer drug and reduce toxicity. By improving the therapeutic index of anticancer drugs, our goal is to turn cancer into a chronic but manageable disease.

The study results were published in the June 15, 2005 in the journal Cancer Research.

The vehicle to take the medication applied by scientists at Michigan is a polymer molecule called a dendrimer whose diameter is less than five nanometers. These dendrimers are small enough to pass through tiny openings in cell membranes.

This image of a dendrimer provided by the University of Michigan shows its structure as a tree with many branches on which scientists can attach a variety of molecules including drugs.

In experiments conducted by the team of Prof. Baker, the investigators adhered methotrexate, a potent anticancer drug, to branches of the dendrimer. In other branches, fluorescent imaging agents joined and a secret ingredient folic acid.

Folic acid is an important vitamin required for healthy functioning of all cells. But it seems that cancer cells need more folic acid than normal. By leveraging its appetite for this material, scientists can prevent cancer cells develop resistance to chemotherapeutic drug treatment.

In laboratory tests, this new therapy with nanoparticles made in mice that received injections of human cancer cells was 10 times more effective and less toxic than traditional treatment administration.

The sooner a cancer is detected, the greater the chances of effective treatment. A team of scientists from different specialties at the University of Missouri-Colombia is investigating the application of nanoparticles to detect and treat cancer at the molecular level. Their main motivation is the early detection of all cancers and as one of the scientists involved in research, early results are very promising.

They are manufactured custom-made nanoparticles for medical applications through a process patented by the University. The research focuses on the use of nanoparticles to detect cancer, even in the pre-cancer through medical imaging techniques.

The idea that doctors would administer millions of nanoparticles programmed to find cancerous tumors. Once the nanoparticles localize the tumor, doctors used X-rays to see it even if they consist of only a single cancer cell, which is now impossible. With current technology, to see the cancer tumor has to be a set of hundreds of cells in a more advanced stage.

In addition, this team of scientists believes that nanoparticles also enhance the effectiveness of current cancer treatments. The soft tissues have limited capacity to absorb the radiation given to treat cancer. If you increase the effective density of the tumor with metallic nanoparticles, a higher dose of radiation reaches the tumor without damaging normal tissue and minimizing side effects.

The research group consists of scientists from the Municipal Institute of Medical Research (IMIM) Barcelona, ​​University Pompeu Fabra (UPF) and the Center for Genomic Regulation (CRG). Spanish is the only group of researchers who participated in this scientific project.

This is the first bird genome sequence and its strategic position in the evolutionary tree of mammals and fish, makes it a unique source of information for the study of vertebrates. Since birds belong to the arcosauromorfos, which also includes crocodiles and dinosaurs, this is the genomic sequence analyzed us most about the dinosaurs.

According to the press release issued yesterday by the IMIM, UPF and the CRG, sequencing, analysis and decoding of the chicken genome has been performed by the International Consortium for Chicken Genome Sequencing, comprising some 50 centers and research laboratories worldwide. According to study results published in Nature, 60% of chicken genes correspond to similar human genes. It is estimated that in the evolution, the genome of the bird and humans began to diverge 310 million years ago.

This latest scientific discovery can play an important role in the study of viruses and cancer, as the first oncogenic virus was identified in chicken. Moreover, the comparative study of genomes of different species opens a line of research that may lead to discover new aspects of human biology and medicine.

A study conducted by a team of scientists and published in Cell (see summary of study here) this month, relieves important information about the development of cancer.

Scientists already know a lot about how they originate and develop tumors, but until now little has been known about how to achieve a cancer metastasize and invade other tissues and organs. Now a team of researchers from MIT and the Whitehead Institute have discovered that tumors spread achieved through its ability to reactivate and lead an inactive protein should have been removed during the embryonic stage.

“As a result, cancer cells acquire in a single step many of the skills they need to execute the complex stages of metastasis” according to Weinberg, a researcher at MIT and director of the research project.

The metastatic process is long and complex as the cancer cells first must invade a nearby tissue, then get the flow of blood or lymphatic vessel. Then they have to migrate through the bloodstream to a new area of ​​the body, leaving the flow and establish a new colony. There are many steps that scientists have always wondered how it was possible that the cells had the capacity to carry them all out.

But according to this new research, do not. Rather than cover the whole process, cancer cells hijack an existing cellular process (“Twist”) and use it to spread through the body.

Twist is a regulator of genes necessary at the stage of embryo development, when it allows the cells to move from one embryo to another site, assigning different tissues. But once developed organism, Twist has no function, and remains dormant in the tissues of the body set up for life. According to recent advances in cancer research, cancer cells fail to reactivate the Twist protein, thus acquiring the ability to move throughout the body

If doctors were able to detect during the first phase of a malignant tumor, the patient could operate much earlier, and remove the tumor without leaving any remaining cancer cells without resorting to chemotherapy.

Until now, methods do exist to analyze the existence or not of a cancerous tumor has been criticized for not being entirely reliable. The type analysis mammograms, PSA (blood test for prostate cancer) and CA-125 (blood test for ovarian cancer) have a high margin of error. According to David Sidransky, a researcher at Johns Hopkins, the PSA system is wrong 33% of the trials and CA-125 system by 50%.

Thanks to recent research by the expert in cancer cell biology and George Wright a new method that analyzes the structure of proteins in the blood, will theoretically identify a tumor with the clarity and accuracy of a fingerprint.

It is already in the first phase of a tumor; cancer distorts the structure of proteins in the blood, so the ability to monitor the structure and detect any abnormality is a revelation. According to Technology Review, are already doing the first tests on humans of such analysis to detect ovarian cancer while developing other tests for prostate, lung, breast, kidney, liver, and lymphatic leukemia?

In the future, perhaps with a single drop of blood can be tested for all types of cancer and achieve dramatically reduce deaths caused by this disease